Clinical Trial Update: A Study to Learn About the Safety of BIIB091 and Its Effect on Brain Inflammation When Taken Alone or With Diroximel Fumarate (DRF) in Adults With Relapsing Forms of Multiple Sclerosis (MS) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluated the safety of BIIB091 and its effect on brain inflammation when taken alone or with diroximel fumarate in adults with relapsi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing Forms of Multiple Sclerosis

Drugs mentioned

• BIIB091
• Diroximel Fumarate (diroximel fumarate)

Snippet

Sponsor: Biogen | Conditions: Relapsing Forms of Multiple Sclerosis | Phase 2 | Status: COMPLETED